- Home
- NBTX vs CFFI Comparison
NBTX vs CFFI Comparison
Compare NBTX & CFFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- CFFI
- Stock Information
- Founded
- NBTX 2003
- CFFI 1927
- Country
- NBTX France
- CFFI United States
- Employees
- NBTX N/A
- CFFI N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- CFFI Major Banks
- Sector
- NBTX Health Care
- CFFI Finance
- Exchange
- NBTX Nasdaq
- CFFI Nasdaq
- Market Cap
- NBTX 201.9M
- CFFI 228.1M
- IPO Year
- NBTX 2020
- CFFI 1998
- Fundamental
- Price
- NBTX $3.25
- CFFI $74.06
- Analyst Decision
- NBTX Strong Buy
- CFFI
- Analyst Count
- NBTX 1
- CFFI 0
- Target Price
- NBTX $12.00
- CFFI N/A
- AVG Volume (30 Days)
- NBTX 42.0K
- CFFI 9.5K
- Earning Date
- NBTX 09-18-2024
- CFFI 01-27-2025
- Dividend Yield
- NBTX N/A
- CFFI 2.33%
- EPS Growth
- NBTX N/A
- CFFI N/A
- EPS
- NBTX N/A
- CFFI 5.66
- Revenue
- NBTX $45,220,186.00
- CFFI $114,783,000.00
- Revenue This Year
- NBTX N/A
- CFFI N/A
- Revenue Next Year
- NBTX N/A
- CFFI N/A
- P/E Ratio
- NBTX N/A
- CFFI $13.10
- Revenue Growth
- NBTX 526.17
- CFFI N/A
- 52 Week Low
- NBTX $2.76
- CFFI $33.51
- 52 Week High
- NBTX $8.43
- CFFI $80.87
- Technical
- Relative Strength Index (RSI)
- NBTX 56.43
- CFFI 56.64
- Support Level
- NBTX $2.85
- CFFI $66.29
- Resistance Level
- NBTX $3.07
- CFFI $72.75
- Average True Range (ATR)
- NBTX 0.16
- CFFI 2.09
- MACD
- NBTX 0.05
- CFFI 0.35
- Stochastic Oscillator
- NBTX 73.67
- CFFI 77.62
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum revenue from the Community Banking segment.